Navigation Links
Sigma-Aldrich (Nasdaq: SIAL) Announces Appointment of George Miller as Sr. Vice President, General Counsel & Secretary
Date:10/1/2009

ST. LOUIS, Oct. 1 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL) is pleased to announce the appointment of George Miller as Sr. Vice President, General Counsel and Secretary. In his new role, Miller will join the company's executive management team and manage its legal services and corporate governance processes. He will report to Jai Nagarkatti, Chairman, President & CEO.

Miller brings to Sigma-Aldrich twenty years of corporate legal experience from large global public companies in the chemical and transportation industries. Prior to his appointment at Sigma-Aldrich, Miller (age 54) was employed by Novartis, most recently as General Counsel in their New York office and previously in their offices in Basel, Switzerland and Tokyo, Japan. Prior to his employment with Novartis, Miller served as Managing Director-Regional Counsel for Federal Express Corporation in their Tokyo, Japan office. Miller earned his Juris Doctorate from Georgetown University Law Center in Washington DC, his Masters of International Management from Thunderbird's Garvin School of International Management, Glendale Arizona, and his Bachelor of Arts from the University of St. Thomas in St. Paul, Minnesota.

Chairman, President and CEO Jai Nagarkatti commented, "We are very pleased to be able to add such a talented professional as George to our organization. In addition to his many years of experience with other global companies, he also has extensive background in enterprise risk management, M&A, board governance, government relations, tax, patent & trademark infringement and litigation. His successful public company General Counsel experience will enhance our overall corporate governance practices and help us better manage legal services in our growing global businesses."

About Sigma-Aldrich: Sigma-Aldrich is a lead
'/>"/>

SOURCE Sigma-Aldrich
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
2. Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock-Out Cell Lines
3. Sigma-Aldrich(R) Receives Award From Michael J. Fox Foundation to Develop Parkinsons Disease Research Models
4. QIAGEN N.V. (Nasdaq: QGEN) Invites You to Join Its Third Quarter 2007 Earnings Conference Call on the Web
5. Webcast of QIAGEN N.V.s (Nasdaq: QGEN) First Quarter 2008 Financial Results Call Set for May 6
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... , August 28, 2014 ... Market Research "Radiofrequency Identification (RFID) Market (Tags, Readers, Middleware, ... Growth, Trends and Forecast, 2014 - 2020" the global ... billion in 2013 and is expected to grow at ... reach an estimated value of USD 5.3 billion in ...
(Date:8/28/2014)... -- In recognition of the increased risks that seniors ... pneumonia, shingles and other illnesses, CVS/pharmacy ® ... be Senior Vaccination Month. Because people,s immune systems ... adults ages 65 years and older stay up ... MinuteClinic nurse practitioners and physician assistants will be ...
(Date:8/28/2014)... , Aug. 28, 2014   Venaxis, Inc.  (Nasdaq: ... on obtaining FDA clearance for and commercializing its CE ... for aiding in identifying children, adolescent, and young adult ... risk for appendicitis, today announced it will present at ... th Annual Global Investment Conference being held in ...
Breaking Medicine Technology:Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 2Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 3Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 4Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 5September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 2September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 3September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 4Venaxis to Present at September Investor Conferences 2Venaxis to Present at September Investor Conferences 3
... CHAPEL HILL, N.C., US, March 06, 2007,/PRNewswire/ ... and,Lantibio, Inc. ("Lantibio") today announced positive final ... clinical,study of Moli1901, an experimental compound to ... by AOP Orphan in,Europe under a licensing ...
... 7, 2007 - BioLineRx Ltd.,(TASE:BLRX), Israel's leading ... trials of BL-1040 demonstrating that,BL-1040 is effective ... myocardial infarction (MI), thereby reducing left ventricle,dilatation ... model. Professor,Jonathan Leor, MD, Director of the ...
Cached Medicine Technology:AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II,Study with Novel Cystic Fibrosis Therapy 2AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II,Study with Novel Cystic Fibrosis Therapy 3AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II,Study with Novel Cystic Fibrosis Therapy 4BioLineRx Presents Data on BL-1040 at Cardiovascular,Revascularization Therapies Conference Demonstrating Potential to,Reduce Deterioration of Infarcted Heart Tissue and Maintain,Functionality 2BioLineRx Presents Data on BL-1040 at Cardiovascular,Revascularization Therapies Conference Demonstrating Potential to,Reduce Deterioration of Infarcted Heart Tissue and Maintain,Functionality 3
(Date:8/28/2014)... Lake Worth, FL (PRWEB) August 28, 2014 ... promote National Recovery Month throughout September. This month ... of addiction treatment and mental health services. Along ... Millennium Treatment Group is helping to spread the ... Month began in 1989, honoring the work of ...
(Date:8/28/2014)... Tempe, Ariz. (PRWEB) August 28, 2014 ... Force Impact Technologies , has been named one ... of the Year competition. , This is the fourth ... finalist in the competition. Jared Schoepf, co-founder of SafeSIPP, ... in 2013 and 2012, respectively. In 2011, ASU dominated ...
(Date:8/28/2014)... American adults who are beginning to research ... now have a simpler way to connect with companies ... year, some of the best life insurance rates available ... The promoted plans that included price data revealed to ... policies. The term, guaranteed and modified plans that might ...
(Date:8/28/2014)... HealthDay Reporter THURSDAY, Aug. 28, 2014 (HealthDay ... symptoms of multiple sclerosis (MS), a new study from Argentina ... D, smoking and Epstein Barr virus infection. Our study shows ... MS patients," said lead researcher Dr. Mauricio Farez, of the ... Multiple sclerosis is a disease of the nervous system that ...
(Date:8/28/2014)... ABC television stars will join forces this Labor Day ... airing Sunday, Aug. 31, 9/8c on ABC television stations ... to help save and improve the lives of children ... into the 2014 telethon to benefit the Muscular Dystrophy ... of the network’s leading stars, including Alyssa Milano of ...
Breaking Medicine News(10 mins):Health News:Millennium Treatment Group Celebrates National Recovery Month 2Health News:Arizona State University Grad Student in the Running for College Entrepreneur of the Year 2Health News:Arizona State University Grad Student in the Running for College Entrepreneur of the Year 3Health News:Best Life Insurance Rates for 2014 Now Promoted at Insurer Website 2Health News:Could Too Much Salt Harm MS Patients? 2Health News:Could Too Much Salt Harm MS Patients? 3Health News:ABC Stars Unite to Fight Back Against Muscle Disease During MDA Show of Strength Telethon 2Health News:ABC Stars Unite to Fight Back Against Muscle Disease During MDA Show of Strength Telethon 3Health News:ABC Stars Unite to Fight Back Against Muscle Disease During MDA Show of Strength Telethon 4
... , , , ... Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic and services ... NewCardio,s QTinno(TM) software suite, NewCardio,s first commercial product, as the ... automated Thorough QT (TQT) studies. , , ...
... , , SAO PAULO, July 30 ... Healthcare is the recipient of the 2009 ... Market. Agfa offers a complete portfolio of solutions including ... CR market, as perceived by the needs of customers willing to ...
... ($ millions, except per-share amounts), ... % Change, ... ... $243 $199 22%, Diluted EPS from Continuing Operations ...
... ... in flexible design with custom mounting, shafts, and low noise plastic and steel gearing options. ... Chatsworth, CA (PRWEB) -- ... planetary gearboxes. These are specially design for the medical industry, as well as for pumps, ...
... ... that it has teamed with Patrick Rummerfield, the first fully functional quadriplegic ... proceeds of the upcoming Golf Classic Tournament to the rehabilitation of an ... have also stepped in to donate a state of the art Functional ...
... ... a less expensive education in the thriving nursing industry. , ... Seattle, Washington (PRWEB) July 30, 2009 -- ... qualified nurse, and online nursing degrees are becoming a popular and effective way to ...
Cached Medicine News:Health News:Top-Five Global Pharmaceutical Company Names NewCardio as its Provider of Automated Thorough QT Solution 2Health News:Top-Five Global Pharmaceutical Company Names NewCardio as its Provider of Automated Thorough QT Solution 3Health News:Top-Five Global Pharmaceutical Company Names NewCardio as its Provider of Automated Thorough QT Solution 4Health News:Frost & Sullivan Awards Agfa Healthcare for Brazilian Market Penetration Leadership in 2009 2Health News:Frost & Sullivan Awards Agfa Healthcare for Brazilian Market Penetration Leadership in 2009 3Health News:Tyco International Reports Third Quarter Earnings from Continuing Operations Before Special Items of $0.58 Per Share and GAAP Earnings of $0.51 Per Share 2Health News:Tyco International Reports Third Quarter Earnings from Continuing Operations Before Special Items of $0.58 Per Share and GAAP Earnings of $0.51 Per Share 3Health News:Tyco International Reports Third Quarter Earnings from Continuing Operations Before Special Items of $0.58 Per Share and GAAP Earnings of $0.51 Per Share 4Health News:Tyco International Reports Third Quarter Earnings from Continuing Operations Before Special Items of $0.58 Per Share and GAAP Earnings of $0.51 Per Share 5Health News:Tyco International Reports Third Quarter Earnings from Continuing Operations Before Special Items of $0.58 Per Share and GAAP Earnings of $0.51 Per Share 6Health News:Tyco International Reports Third Quarter Earnings from Continuing Operations Before Special Items of $0.58 Per Share and GAAP Earnings of $0.51 Per Share 7Health News:Tyco International Reports Third Quarter Earnings from Continuing Operations Before Special Items of $0.58 Per Share and GAAP Earnings of $0.51 Per Share 8Health News:Tyco International Reports Third Quarter Earnings from Continuing Operations Before Special Items of $0.58 Per Share and GAAP Earnings of $0.51 Per Share 9Health News:Tyco International Reports Third Quarter Earnings from Continuing Operations Before Special Items of $0.58 Per Share and GAAP Earnings of $0.51 Per Share 10Health News:Tyco International Reports Third Quarter Earnings from Continuing Operations Before Special Items of $0.58 Per Share and GAAP Earnings of $0.51 Per Share 11Health News:Tyco International Reports Third Quarter Earnings from Continuing Operations Before Special Items of $0.58 Per Share and GAAP Earnings of $0.51 Per Share 12Health News:Tyco International Reports Third Quarter Earnings from Continuing Operations Before Special Items of $0.58 Per Share and GAAP Earnings of $0.51 Per Share 13Health News:Tyco International Reports Third Quarter Earnings from Continuing Operations Before Special Items of $0.58 Per Share and GAAP Earnings of $0.51 Per Share 14Health News:Tyco International Reports Third Quarter Earnings from Continuing Operations Before Special Items of $0.58 Per Share and GAAP Earnings of $0.51 Per Share 15Health News:Tyco International Reports Third Quarter Earnings from Continuing Operations Before Special Items of $0.58 Per Share and GAAP Earnings of $0.51 Per Share 16Health News:Tyco International Reports Third Quarter Earnings from Continuing Operations Before Special Items of $0.58 Per Share and GAAP Earnings of $0.51 Per Share 17Health News:Tyco International Reports Third Quarter Earnings from Continuing Operations Before Special Items of $0.58 Per Share and GAAP Earnings of $0.51 Per Share 18Health News:Tyco International Reports Third Quarter Earnings from Continuing Operations Before Special Items of $0.58 Per Share and GAAP Earnings of $0.51 Per Share 19Health News:Tyco International Reports Third Quarter Earnings from Continuing Operations Before Special Items of $0.58 Per Share and GAAP Earnings of $0.51 Per Share 20Health News:Tyco International Reports Third Quarter Earnings from Continuing Operations Before Special Items of $0.58 Per Share and GAAP Earnings of $0.51 Per Share 21Health News:Tyco International Reports Third Quarter Earnings from Continuing Operations Before Special Items of $0.58 Per Share and GAAP Earnings of $0.51 Per Share 22Health News:Tyco International Reports Third Quarter Earnings from Continuing Operations Before Special Items of $0.58 Per Share and GAAP Earnings of $0.51 Per Share 23Health News:Tyco International Reports Third Quarter Earnings from Continuing Operations Before Special Items of $0.58 Per Share and GAAP Earnings of $0.51 Per Share 24Health News:Tyco International Reports Third Quarter Earnings from Continuing Operations Before Special Items of $0.58 Per Share and GAAP Earnings of $0.51 Per Share 25Health News:Tyco International Reports Third Quarter Earnings from Continuing Operations Before Special Items of $0.58 Per Share and GAAP Earnings of $0.51 Per Share 26Health News:Tyco International Reports Third Quarter Earnings from Continuing Operations Before Special Items of $0.58 Per Share and GAAP Earnings of $0.51 Per Share 27Health News:Tyco International Reports Third Quarter Earnings from Continuing Operations Before Special Items of $0.58 Per Share and GAAP Earnings of $0.51 Per Share 28Health News:Tyco International Reports Third Quarter Earnings from Continuing Operations Before Special Items of $0.58 Per Share and GAAP Earnings of $0.51 Per Share 29Health News:New Custom Hybrid Planetary Gearbox Series from NMB 2Health News:Patrick Rummerfield Teams with Eric Westacott Foundation and Christopher and Dana Reeve Foundation to Help Young Quadriplegic Boy 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: